Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2023 Filed May 18, 2023 21:20 UTC |
Lucera ErickEVP, CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 77,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008293 · form4-05182023_090554.xml · nonDerivative · entry 1 Lucera Erick · CIK 0001697616 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,900 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on May 17, 2024 continuing through May 17, 2027. Read SEC document |
| May 11, 2023 Filed May 15, 2023 16:30 UTC |
Eaton BruceEVP, CBO AND CTO
|
SaleCommon Stock | 668 | $9.87 | $6,594.50 |
DisclosureSEC source: 0001415889-23-007989 · form4-05152023_040501.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CBO AND CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,779 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 10, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 949 | $9.87 | $9,368.53 |
DisclosureSEC source: 0001415889-23-007990 · form4-05152023_040503.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,610 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 10, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 09, 2023 Filed May 11, 2023 16:30 UTC |
Eaton BruceEVP, CBO AND CTO
|
SaleCommon Stock | 135 | $9.51 | $1,283.85 |
DisclosureSEC source: 0001415889-23-007816 · form4-05112023_040501.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CBO AND CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,447 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 6, 2023. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $9.5100 to $9.5150.The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 20:53 UTC |
Levy Elliott M.Director
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $6.71 | $0.00 |
DisclosureSEC source: 0001415889-23-006521 · form4-04132023_080436.xml · derivative · entry 1 Levy Elliott M. · CIK 0001858745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-04-10 F1 · derivative.exercise_date: This option was granted on April 11, 2023 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on April 11, 2024 through April 11, 2026. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 16:30 UTC |
Eaton BruceEVP, CBO AND CTO
|
SaleCommon Stock | 101 | $8.89 | $897.89 |
DisclosureSEC source: 0001415889-23-004312 · form4-03062023_040302.xml · nonDerivative · entry 2 Eaton Bruce · CIK 0001874831 · EVP, CBO AND CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,582 F2 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 184 | $8.89 | $1,635.76 |
DisclosureSEC source: 0001415889-23-004315 · form4-03062023_040309.xml · nonDerivative · entry 2 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,559 F2 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 16:30 UTC |
Eaton BruceEVP, CBO AND CTO
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001415889-23-004312 · form4-03062023_040302.xml · derivative · entry 3 Eaton Bruce · CIK 0001874831 · EVP, CBO AND CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-03-01 F3 · derivative.exercise_date: This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 16:30 UTC |
Eaton BruceEVP, CBO AND CTO
|
GrantCommon Stock | 16,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004312 · form4-03062023_040302.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CBO AND CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,683 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 94,500 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001415889-23-004315 · form4-03062023_040309.xml · derivative · entry 3 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,500 Underlying: Common Stock · 94,500 shares Expires 2033-03-01 F3 · derivative.exercise_date: This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 31,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004315 · form4-03062023_040309.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,743 F1 · security: The common stock received by the Reporting person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:30 UTC |
Mei BaisongSVP, CHIEF MEDICAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 54,000 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001415889-23-004314 · form4-03062023_040307.xml · derivative · entry 2 Mei Baisong · CIK 0001938499 · SVP, CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2033-03-01 F2 · derivative.exercise_date: This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:30 UTC |
Mei BaisongSVP, CHIEF MEDICAL OFFICER
|
GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004314 · form4-03062023_040307.xml · nonDerivative · entry 1 Mei Baisong · CIK 0001938499 · SVP, CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,372 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:30 UTC |
O'Neill Gilmore NeilDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001415889-23-004313 · form4-03062023_040304.xml · derivative · entry 2 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-01 F2 · derivative.exercise_date: This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:30 UTC |
O'Neill Gilmore NeilDirector · CEO
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004313 · form4-03062023_040304.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,655 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 16:30 UTC |
Eaton BruceEVP, CBO AND CTO
|
SaleCommon Stock | 3,307 | $9.67 | $31,963.15 |
DisclosureSEC source: 0001415889-23-002602 · form4-02152023_040201.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CBO AND CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,983 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 4,287 | $9.67 | $41,435.14 |
DisclosureSEC source: 0001415889-23-002603 · form4-02152023_040208.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,243 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 16:30 UTC |
Shearman Mark SEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 2,790 | $9.67 | $26,966.19 |
DisclosureSEC source: 0001415889-23-002604 · form4-02152023_040213.xml · nonDerivative · entry 1 Shearman Mark S · CIK 0001643799 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,559 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 16:30 UTC |
Eaton BruceEVP, CBO AND CTO
|
SaleCommon Stock | 346 | $11.10 | $3,840.60 |
DisclosureSEC source: 0001415889-23-002218 · form4-02092023_040202.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CBO AND CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,290 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 6, 2023. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,752 | $8.16 | $14,296.50 |
DisclosureSEC source: 0001415889-23-000875 · form4-01122023_040101.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,530 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30,2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 9,2023. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $8.1600 to $8.1911. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 16:30 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 102 | $10.23 | $1,043.46 |
DisclosureSEC source: 0001415889-22-012131 · form4-12062022_041201.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,636 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| December 05, 2022 Filed Dec 6, 2022 21:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 193 | $10.23 | $1,974.39 |
DisclosureSEC source: 0001415889-22-012132 · form4-12062022_041206.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,282 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 16:30 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 289 | $11.02 | $3,184.78 |
DisclosureSEC source: 0001415889-22-011242 · form4-11092022_041141.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,738 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 16:30 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 101 | $15.01 | $1,516.01 |
DisclosureSEC source: 0001415889-22-009448 · form4-09082022_040901.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,027 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 20:30 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 192 | $15.01 | $2,881.92 |
DisclosureSEC source: 0001415889-22-009449 · form4-09082022_040910.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,475 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 16:30 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 293 | $18.60 | $5,449.39 |
DisclosureSEC source: 0001415889-22-008463 · form4-08102022_040801.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,128 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2022. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.0525 to $18.61. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 20:36 UTC |
Mei BaisongSVP, CHIEF MEDICAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 171,602 | $0.00 Strike: $14.99 | $0.00 |
DisclosureSEC source: 0001415889-22-007838 · form4-07202022_010742.xml · derivative · entry 2 Mei Baisong · CIK 0001938499 · SVP, CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,602 Underlying: Common Stock · 171,602 shares Expires 2032-07-17 F2 · derivative.exercise_date: This option was granted on July 18, 2022 and is scheduled to vest over four years, with 25% of the shares to vest on July 18, 2023 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 18, 2026. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 20:36 UTC |
Mei BaisongSVP, CHIEF MEDICAL OFFICER
|
GrantCommon Stock | 58,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007838 · form4-07202022_010742.xml · nonDerivative · entry 1 Mei Baisong · CIK 0001938499 · SVP, CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,372 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 18, 2023 continuing through July 18, 2026. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 16:15 UTC |
Shearman Mark SEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 5,145 | $10.06 | $51,744.81 |
DisclosureSEC source: 0001415889-22-006631 · form4-06162022_040601.xml · nonDerivative · entry 1 Shearman Mark S · CIK 0001643799 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,349 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 14, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Vaishnaw AkshayDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001415889-22-006492 · form4-06132022_040621.xml · derivative · entry 1 Vaishnaw Akshay · CIK 0001458494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Hirsch AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001415889-22-006489 · form4-06132022_040606.xml · derivative · entry 1 Hirsch Andrew · CIK 0001586707 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023 Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Hopfield JessicaDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001415889-22-006490 · form4-06132022_040611.xml · derivative · entry 1 Hopfield Jessica · CIK 0001648715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Connaughton BernadetteDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001415889-22-006494 · form4-06132022_040635.xml · derivative · entry 1 Connaughton Bernadette · CIK 0001662521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Reeve EmmaDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001415889-22-006493 · form4-06132022_040629.xml · derivative · entry 1 Reeve Emma · CIK 0001680329 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Scadden DavidDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001415889-22-006491 · form4-06132022_040616.xml · derivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Chatterjee MeetaDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.31 | $0.00 |
DisclosureSEC source: 0001415889-22-006488 · form4-06132022_040601.xml · derivative · entry 1 Chatterjee Meeta · CIK 0001835388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 16:46 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 1,123 | $11.54 | $12,955.94 |
DisclosureSEC source: 0001415889-22-006162 · form4-06062022_010614.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,421 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 20:45 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,527 | $11.54 | $17,616.85 |
DisclosureSEC source: 0001415889-22-006161 · form4-06062022_010617.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,667 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:44 UTC |
O'Neill Gilmore NeilDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 950,209 | $0.00 Strike: $11.54 | $0.00 |
DisclosureSEC source: 0001415889-22-006159 · form4-06062022_010612.xml · derivative · entry 2 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,209 Underlying: Common Stock · 950,209 shares Expires 2032-06-01 F2 · derivative.exercise_date: This option was granted on June 2, 2022 and is scheduled to vest over four years, with 25% of the shares scheduled to vest on June 2, 2023 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:44 UTC |
O'Neill Gilmore NeilDirector · CEO
|
GrantCommon Stock | 86,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006159 · form4-06062022_010612.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,655 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on June 2, 2023 continuing through June 2, 2026. Read SEC document |
| May 09, 2022 Filed May 11, 2022 16:15 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 297 | $13.11 | $3,894.50 |
DisclosureSEC source: 0001415889-22-004837 · form4-05112022_040501.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,544 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on May 6, 2022. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.8768 to $13.12. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 14, 2022 Filed Apr 18, 2022 16:15 UTC |
MULLEN JAMES CDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 170,989 | $0.00 Strike: $45.69 | $0.00 |
DisclosureSEC source: 0001415889-22-004098 · form4-04182022_040401.xml · derivative · entry 1 MULLEN JAMES C · CIK 0001226288 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,989 Underlying: Common Stock · 170,989 shares Expires 2031-03-01 F1 · derivative.exercise_date: Reflects the vesting, upon the satisfaction of the performance criteria, of a portion of a performance-based stock option originally granted on March 2, 2021. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 16:30 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 1,258 | $19.64 | $24,707.37 |
DisclosureSEC source: 0001415889-22-003709 · form4-04042022_040401.xml · nonDerivative · entry 2 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,841 F2 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 31, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 16:15 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
SaleCommon Stock | 403 | $17.33 | $6,983.06 |
DisclosureSEC source: 0001415889-22-002656 · form4-03072022_040308.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,386 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 21:15 UTC |
ROBERTSON MICHELLEEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 767 | $17.33 | $13,290.35 |
DisclosureSEC source: 0001415889-22-002655 · form4-03072022_040301.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,194 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2022. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 16:22 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
GrantStock Option (right to buy) · Derivative | 110,732 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001415889-22-001225 · form4-02112022_010246.xml · derivative · entry 2 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,732 Underlying: Common Stock · 110,732 shares Expires 2032-02-09 F2 · derivative.exercise_date: This option was granted on February 10, 2022 and is scheduled to vest over four years in equal monthly installments beginning on March 10, 2022 through February 10, 2026. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 16:22 UTC |
Eaton BruceEVP, CHIEF BUSINESS OFFICER
|
GrantCommon Stock | 37,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-001225 · form4-02112022_010246.xml · nonDerivative · entry 1 Eaton Bruce · CIK 0001874831 · EVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,789 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on February 10, 2023 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 10, 2026. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:20 UTC |
ROBERTSON MICHELLECHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 157,580 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001415889-22-001223 · form4-02112022_010242.xml · derivative · entry 2 ROBERTSON MICHELLE · CIK 0001755098 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,580 Underlying: Common Stock · 157,580 shares Expires 2032-02-09 F2 · derivative.exercise_date: This option was granted on February 10, 2022 and is scheduled to vest over four years in equal monthly installments beginning on March 10, 2022 through February 10, 2026. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:20 UTC |
ROBERTSON MICHELLECHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 53,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-001223 · form4-02112022_010242.xml · nonDerivative · entry 1 ROBERTSON MICHELLE · CIK 0001755098 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,961 F1 · security: The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on February 10, 2023 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 10, 2026. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 16:21 UTC |
Shearman Mark SEVP, CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (right to buy) · Derivative | 93,398 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001415889-22-001224 · form4-02112022_010249.xml · derivative · entry 2 Shearman Mark S · CIK 0001643799 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,398 Underlying: Common Stock · 93,398 shares Expires 2032-02-09 F2 · derivative.exercise_date: This option was granted on February 10, 2022 and is scheduled to vest over four years in equal monthly installments beginning on March 10, 2022 through February 10, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.